EBM-Diagnostic Testing K. Mae Hla, MD, MHS Primary Care Faculty Development Fellowship November 13, 2010.

Slides:



Advertisements
Similar presentations
Lecture 3 Validity of screening and diagnostic tests
Advertisements

Testing for DVT/PE Steve Kizer MD. Why do the strategies for testing for thromboembolic disease seem so difficult? Confusion as to the goals of treatment.
TESTING A TEST Ian McDowell Department of Epidemiology & Community Medicine November, 2004.
Divisional Meeting 15 th January 2009 Streptococcal Pharyngitis: A Systematic Review of the Predictive Value of Signs and Symptoms and the External Validation.
Is it True? Evaluating Research about Diagnostic Tests
Critically Evaluating the Evidence: diagnosis, prognosis, and screening Elizabeth Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management.
Diagnosing Pulmonary Embolism in 2003 Dr. Peter Jones Emergency Medicine Specialist Auckland Hospital.
Evaluation of Diagnostic Test Studies
Evidence-Based Diagnosis in Physical Therapy Julie M. Fritz, PhD, PT, ATC Department of Physical Therapy University of Pittsburgh.
Journal Club Alcohol and Health: Current Evidence July–August 2005.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2010.
Making sense of Diagnostic Information Dr Carl Thompson.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
D-dimer in the Diagnosis of Pulmonary Embolism Cheryl Pollock PGY-3.
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Asking Questions Robert M. Rowell, DC, MS.
Information Mastery: A Practical Approach to Evidence-Based Care Course Directors: Allen Shaughnessy, PharmD, MMedEd David Slawson, MD Tufts Health Care.
Diagnosis Concepts and Glossary. Cross-sectional study The observation of a defined population at a single point in time or time interval. Exposure and.
HOW TO READ AN ARTICLE ABOUT A DIAGNOSTIC TEST Chitkara MB, Boykan R, Messina C Stony Brook Long Island Children’s Hospital.
Statistics in Screening/Diagnosis
Diagnosis Articles Much Thanks to: Rob Hayward & Tanya Voth, CCHE.
DEB BYNUM, MD AUGUST 2010 Evidence Based Medicine: Review of the basics.
EBM --- Journal Reading Presenter :李政鴻 Date : 2005/10/26.
Division of Population Health Sciences Royal College of Surgeons in Ireland Coláiste Ríoga na Máinleá in Éirinn Indices of Performances of CPRs Nicola.
Studies of Diagnostic Tests Thomas B. Newman, MD, MPH October 16, 2008.
Vanderbilt Sports Medicine How to practice and teach EBM Chapter 3 May 3, 2006.
Session 4: Assessing a Document on Diagnosis Peter Tarczy-Hornoch MD Head and Professor, Division of BHI Professor, Division of Neonatology Adjunct Professor,
Evidence Based Medicine Workshop Diagnosis March 18, 2010.
Screening and Diagnostic Testing Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University.
Evaluation of Diagnostic Tests
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
+ Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class September 15, 2008.
Design and Analysis of Clinical Study 6. Case-control Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
INTRODUCTION Upper respiratory tract infections, including acute pharyngitis, are common in general practice. Although the most common cause of pharyngitis.
Diagnosis: EBM Approach Michael Brown MD Grand Rapids MERC/ Michigan State University.
Appraising A Diagnostic Test
Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology.
Evidence-Based Medicine Diagnosis Component 2 / Unit 5 1 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
1. Statistics Objectives: 1.Try to differentiate between the P value and alpha value 2.When to perform a test 3.Limitations of different tests and how.
Statistics for the board September 14 th 2007 Jean-Sebastien Rachoin MD.
DIAGNOSTIC & SCREENING Evidence-based Medicine. Pengalaman/Data Empiric Masalah experience-based medicine Nilai-nilai kebenaran Nilai-nilai pembenaran.
Welcome Back From Lunch. Thursday Afternoon 2:00-3:00 Studies of Diagnostic Test Accuracy (Tom) 3:00-3:45 Combining Tests (Mark) 3:45-4:00 Break 4:00-5:30.
ANKLE INJURIES Dan O’Connell, MD Department of Family Practice.
Section C Maranion – Mendoza. Subjective Pertinent PositivePertinent Negative 28 y/o female CC: Hemoptysis Chronic cough No weight change No change in.
Diagnostic Tests Studies 87/3/2 “How to read a paper” workshop Kamran Yazdani, MD MPH.
SCH Journal Club Use of time from fever onset improves the diagnostic accuracy of C-reactive protein in identifying bacterial infections Wednesday 13 th.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Excluding the Diagnosis of Pulmonary Embolism: Is There a Magic Ball? COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
CLINICAL EPIDEMIOLOGY III: JOURNAL APPRAISAL Group 3 February 11, 2010.
Diagnostic Test Characteristics: What does this result mean
EBM --- Journal Reading Presenter :傅斯誠 Date : 2005/10/26.
Common Errors by Teachers and Proponents of EBM
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Clinical Decision on A Diagnostic Test. Clinical Question In a middle aged man with primary gout and azotemia, can a urine uric acid to creatinine ratio.
Shoulder Objective Examination How to Interpret Special Tests.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Role of Tests and Measures in Clinical Practice Paul Mintken PT, DPT, OCS, FAAOMPT Associate Editor, Tests & Measures, PTNow Associate Professor Physical.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Critical Appraisal Course for Emergency Medicine Trainees Module 5 Evaluation of a Diagnostic Test.
Diagnosis Recitation. The Dilemma At the conclusion of my “diagnosis” presentation during the recent IAPA meeting, a gentleman from the audience asked.
Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients Thrombosis Research (2008)
Diagnostic studies Adrian Boyle.
Diagnostic Test Studies
When is the post-test probability sufficient for decision-making?
Sensitivity and Specificity
Evidence-Based Medicine
Refining Probability Test Informations Vahid Ashoorion MD. ,MSc,
Diagnosis General Guidelines:
Evidence Based Diagnosis
Presentation transcript:

EBM-Diagnostic Testing K. Mae Hla, MD, MHS Primary Care Faculty Development Fellowship November 13, 2010

Objectives Develop pre-test probabilities Derive treatment thresholds Appraise evidence about a diagnostic test -validity, accuracy and applicability Calculate the results of diagnostic tests - sensitivity, specificity and likelihood ratios Apply evidence to patient care decisions

The Diagnostic Process Working diagnosis- pretest probability With each new finding/test we move from the pre-test probability to a new post-test probability Clinicians estimate probability of disease using probabilistic, prognostic and pragmatic approaches Compare disease probabilities to two thresholds

Applying Diagnostic Tests Example #1 8-year-old with fever, sore throat, swollen cervical glands and tonsillar exudates. No h/o cough. You order a rapid strep test.

What’s your pretest probability of the patient having group A strep pharyngitis? How much of a change would help you decide to treat, not treat or test further?

Treatment Thresholds ZONE OF UNCERTAINTY No Tx Tx 0% 100% Probability of Strep Pharyngitis 5%90%

Rapid Strep Test Results Rapid Strep test result comes back negative How does the rapid strep test result change the probability of the patient having or not having the disease? A positive rapid strep test raises post test probability of strep pharyngitis to 85% in one study A negative strep test decreases probability to 12 %

Pre-test Prob = 40% LR+ = LR- =

Treatment Thresholds ZONE OF UNCERTAINTY No Tx Tx 0% 12% 100% Probability of strep when rapid strep test is negative X 5%90%

Example #2 18-year-old female with ankle pain after a roller-blading accident. States unable to walk on her injured ankle. Exam demonstrates a slightly swollen ankle but no tenderness noted. Able to bear weight and take 4 full steps upon encouragement. What is the probability of ankle fracture? Do you need to order an ankle x-ray?

Ottowa Ankle rule An ankle x-ray is only necessary if there is pain near the malleoli and any of the following findings are present: inability to bear wt. both immediately and in the ED bone tenderness at the posterior edge or tip of the malleolus

How accurate is the Ottowa ankle rule in ruling out ankle fracture? A prospective validation study in > 1000 pts presenting to the ED with ankle pain Likelihood ratio + = 1.96 Likelihood ratio - = 0

Pre-test Prob = 10% LR+ = LR- =

Case 1 75-year-old woman with a hemoglobin of 10, MCV was 80 on routine checkup, a negative history and physical except osteoarthritis, and on no meds likely to suppress her marrow or cause a bleed Her probability of iron deficiency was 50% You want to avoid doing a bone marrow and order serum ferritin to diagnose iron deficiency anemia

Case 1 P: In an elderly symptomless woman with mild anemia I: how useful is serum ferritin C: O: in diagnosing iron deficiency anemia T(ype of question): Diagnosis T(ype of study): Prospective Cohort *Diagnosis of Iron Deficiency Anemia in the Elderly (Guyatt, et al. Am J Med, 1990;(88):

Three Main Questions Validity-Is this evidence about the accuracy of a diagnostic test valid? Results-Does this evidence show that this test can adequately distinguish patients who do and do not have the disorder? Applicability-How can I apply this valid, accurate diagnostic test to a specific patient?

Validity Measurement: was the gold standard measured independently? Representative: was the test evaluated in appropriate spectrum of patients? Ascertainment: was the reference test ascertained regardless of the diagnostic test?

All patients in study should have both the diagnostic test in question (blood test, history, physical exam) and the gold/reference standard test (autopsy, bone marrow, biopsy, angiogram) Independent- test not part of gold standard, decision to perform gold standard should not depend on result of diagnostic test under study Blinding- reference test readers should be unaware of results to avoid bias if tests/gold standard have subjective component- x-rays, biopsy, slides Validity- Measurement

Validity: Measurement Was there an independent blind comparison with a reference gold standard? The gold standard was the bone marrow aspirate results All patients got the serum ferritin and bone marrow done independently Marrow aspirates and iron deficiency status was determined by 2 hematologists unaware of the lab result

Validity: Representative Was the diagnostic test evaluated in an appropriate spectrum of patients? Examples: risk markers such as CEA were initially done in high risk patients

Validity: Representative Diagnostic uncertainty Patients with mild as well as severe symptoms Patients with early as well as late disease Patients with other commonly confused diagnoses

Study spectrum representative? Consecutive patients age 65 or older with anemia were recruited 36% of patients had iron deficiency anemia 44% had anemia of chronic disease 8% megaloblastic anemia Patients with other commonly confused disorders- different types of anemia and chronic medical conditions were included

Validity: Ascertainment Was the reference standard ascertained regardless of the diagnostic test result? Did all patients in the study both with and without iron deficiency anemia get the bone marrow done? Yes

Patients with negative diagnostic test may not get the gold standard done if the latter is invasive How do we prove for sure that the ones with negative tests truly do not have the disease or vice versa? Other ways to establish reference test Ascertainment-Continued

In the Pioped study looking at the utility of V/Q scan in patients with suspected pulmonary embolism-all patients with negative V/Q scan did not get pulmonary angiogram Clinical followup in a year was the additional reference standard to not miss patients with false negative VQ results

Results Does the test accurately distinguish between patients with and without the disorder? – –Sensitivity and specificity – –Likelihood ratios

Disease PresentAbsent Test Positive aba+b Negative cdc+d a+cb+d

Disease PresentAbsent Test Positive aTPb FP FPa+b Negative cFNd TN TNc+d a+cb+d

Disease PresentAbsent Test Positive aTPb FP FPa+b Negative cFNdTNc+d a+cSen=a/a+cb+dSp=d/d+b

Disease PresentAbsent Test Positive aTPb a+b Negative cFNdTNc+d a+cSen=a/a+cSp=d/d+bb+d“PID”“NIH”

Sensitive test-rules out the disease (SnNout) Test with high sensitivity (high TPR and very low false negative rate), negative test rules out the disease Examples: loss of retinal vein pulsation in increased intracranial pressure-the presence of pulsation (negative test) rules out IIP HIV antibody- negative test rules out HIV

Specific test – rules in the disease (SpPIN) Test with high specificity (high TNR, very low FPR)-positive test rules in the diagnosis Features of child with Down’s syndrome- very specific Presence of features (positive test) rules in the diagnosis Western blot confirmatory testing for HIV- high specificity: positive test rules in HIV disease

Likelihood Ratio likelihood of the test result in patients with the disease likelihood of the same result in patients without disease LR =

Disease PresentAbsent Test Positive aTPb FP FPa+b Negative cFNdTNc+d a+cSen=a/a+cb+dSp=d/d+b (+)LR= + test result in pts with dz (-)LR= - test result in pts with dz + test result in pts without dz - test result in pts without dz + test result in pts without dz - test result in pts without dz

Disease PresentAbsent Test Positive aTPb FP FPa+b Negative cFNdTNc+d a+cSen=a/a+cb+dSp=d/d+b (+)LR= + test result in pts with dz (-)LR= - test result in pts with dz + test result in pts without dz - test result in pts without dz + test result in pts without dz - test result in pts without dz = Sn/1-Sp = 1-Sn/Sp

Likelihood Ratio probability of the test result in patients with the disease probability of the same result in patients without disease LR =

Pre-Test Probability Pre-Test Odds Post-Test Odds Post-Test Probability Odds = Probability/1-probability Probability = Odds/1 + Odds

What do all these numbers mean?!? L.R.s indicate by how much a given diagnostic test result will raise or lower the pre-test probability of the target disorder L.R. of 1 = post-test probability is same as pre- test probability L.R. > 1 increases the probability that the target disorder is present; the higher the L.R., the greater the increase L.R. < 1 decreases the probability of the target disorder; the smaller the L.R., the greater the decrease

Effects of different likelihood ratios >10 or <0.1 generate large and often conclusive changes from pre- to post- test probability 5-10 and generate moderate shifts in pre- to post-test probability Depending on pre-test probability, change may or may not be large enough to influence Rx decision

Back to our patient Our patient’s serum ferritin comes back at 40 mmol/L How should we put all this together?

Iron Deficiency Anemia PresentAbsent Test Positive < a 15 15b Negative>45 c d135 a+c a+cb+da+b+c+d Totals

Low ferritin (<45) in diagnosing Fe def anemia Prevalence (study pre-test probability) = 85/235= 36% Sensitivity= True positive / all with disease = a/a+c = 70/85 = 82% Specificity = True neg / all without disease = d/b+d = 135/150 = 90%

Low ferritin (<45) in diagnosing iron deficiency anemia L.R.+ = sensitivity/(1-specificity) = 82%/10% = 8.2 L.R. -= (1-sens)/spec = 18%/90% = 0.2

Simplifying Likelihood Ratio Calculations Bone Marrow: iron deficient Bone Marrow: normal iron Test Results: < > Totals85150

Calculating Likelihood Ratios at 45 cut point Bone Marrow: iron deficient Bone Marrow: normal iron Likelihood Ratios Test Results: < /85= /150= /0.1= > /85= /150= /0.9= Totals85150

Pre-test Prob = 36% LR+ = LR- =

Applying the Test to the Patient Is the diagnostic test available, affordable, accurate and precise in our setting? Yes

Applicability (cont’d) Test needs to be available, affordable Interpreted in competent, reproducible fashion in clinical setting Potential consequences should justify the cost

Applicability (Cont’d) Are the study patients similar to our own? Are the results applicable to the patient in my practice? Will the patient be better off as a result of the test?

Applicability-study patients’ characteristics 235/259 patients had interpretable aspirates Mean age 79.7, 46% men, 72% had no medical diagnosis other than anemia Early dementia 25 CHF 25 COPD 25 Rheumatoid arthritis 17 Osteoarthritis 14 Pneumonia 13

Can we generate a clinically sensible estimate of our patient’s pre-test probability? How can we estimate pre-test probability? Clinical experience Regional or national prevalence statistics Practice databases Pretest probability observed in the study itself Studies of pre-test probabilities

Low = 3.6% (2-6) Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the SimpliRED D-dimer. Thromb Haemost 2000;83: Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the SimpliRED D-dimer. Thromb Haemost 2000;83: Risk of PE Inter = 20% (17-24) High = 67% (54-77)

Will the post-test probabilities affect our management and help our patient? Could the test result move us across a test-treatment threshold? Would the patient be willing to undergo the test? Would it help the patient?

Pre-test Prob = 50% LR+ = LR- =

Treatment Thresholds ZONE OF UNCERTAINTY No Tx Tx 0% 100% 90% Probability of Fe def Anemia when Ferritin is <45 10%90% x

Likelihood Ratios for 4 levels of Serum Ferritin Ferritin Fe def # Not Fe def L.R. < >18 18< >45 45< > Total85150

Calculating Likelihood Ratios Bone Marrow: iron deficient Bone Marrow: normal iron Likelihood Ratios Test Results: < /85= /150= /0.013= /85= /150= /0.087= /85= /150= /0.18= >10088/85= /150= /0.72= Totals85150

Clinical Scenario 52 y.o. male admitted to Orthopedics 3 days ago for a R femur fracture after falling from a ladder 52 y.o. male admitted to Orthopedics 3 days ago for a R femur fracture after falling from a ladder Underwent ORIF 2 days ago Underwent ORIF 2 days ago Last night developed SOB Last night developed SOB No CP or cough No CP or cough PE: Afeb 115/70 HR 110 RR 18 95% on 4L PE: Afeb 115/70 HR 110 RR 18 95% on 4L –Otherwise unremarkable (Lungs clear, No elevated JVP or RV heave, no lower ext swelling) Labs: EKG sinus tach, CXR clear Labs: EKG sinus tach, CXR clear D-dimer 0.5 mcg/mL (nl <0.6) D-dimer 0.5 mcg/mL (nl <0.6)

PICO P: In a patient with acute onset of SOB, hypoxia and sinus tachycardia after a major orthopedic surgery for femur fracture I: Does a negative D-dimer result C: O: Rule out pulmonary embolism T(ype of question): Diagnosis T(ype of study): Prospective Cohort *De Monye W et al: The performance of two rapid d-dimer assays in 287 patients with clinically suspected pulmonary embolism. Thrombosis Res 2002;(107):

Low = 3.6% (2-6) Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the SimpliRED D-dimer. Thromb Haemost 2000;83: Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the SimpliRED D-dimer. Thromb Haemost 2000;83: Risk of PE Inter = 20% (17-24) High = 67% (54-77)

Treatment Thresholds ZONE OF UNCERTAINTY No Tx Tx 0% 20% 100% Probability of Pulm Embolism X 5%90%

Sensitivity and Specificity Sensitivity (“Positive in disease”) = true pos / all disease = 74 / 90 = 82.2% Specificity (“Negative in health”) = true neg/all disease free = 120 / 197 = 60.3%

Likelihood Ratios of D-Dimer Test Likelihood ratio (+) = (74 / 90) / (77/197) = 2.1 Likelihood ratio (-) = (16/90) / (120/197) = 0.29

LR+ = LR- = Pre-test Prob = 20%

Treatment Thresholds ZONE OF UNCERTAINTY No Tx Tx 0% 5% 100% Probability of Pulm Embolism if D-Dimer is negative X 5%90%

LR (using lower cut off 95% sensitive D-Dimer value) Likelihood ratio + test = (86/90) / (149/197) = 1.3 Likelihood ratio - test = (4/90) / (48/197) = 0.18 probability of the test result in patients with the disease probability of the same result in patients without disease LR =

LR+ = LR- = Pre-test Prob = 20%

Treatment Thresholds ZONE OF UNCERTAINTY No Tx Tx 0% 100% 3% Probability of PE if D-Dimer is negative 3% 90% x

Summary Develop pre-test probabilities Steps in appraising a diagnostic test Calculate and interpret sensitivity, specificity and likelihood ratios Evaluate how pre-test probability and likelihood ratio results affect post-test probability of disease to influence further testing or treatment decisions